Please assess the completion status of the following clinical trial:

Trial Title: Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* asthma diagnosis according to ATS criteria,~* lung function (FEV1) above 60% of predicted,~* AMP-PC20 below 160 mg/ml with a documented fall in FEV1 of 30% in this provocation test~Exclusion Criteria:~* having smoked \> 10 Pack-years,~* hypersensitivity to one of the study drugs,~* significant co-morbidity, pregnancy or lactating

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).